
APDN Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
April 1st, 2021
APDN Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
April 1st, 2021
Applied DNA to Participate in Upcoming Conferences
March 8th, 2021
FY’21 Q1 Revenues at Upper End of Guided Range
February 11th, 2021
Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021
February 5th, 2021
Applied DNA Promotes Judy Murrah to COO
January 20th, 2021
Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 13th, 2021
Pricing of $15M Registered Direct Offering
January 11th, 2021
APDN to Participate in H.C. Wainwright BIOCONNECT 2021 Conference
January 5th, 2021
Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million
January 4th, 2021